Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib
Annals of Hematology(2024)
摘要
We evaluated RDW in a single-center series of 61 consecutive patients with primary and secondary MF at diagnosis and during treatment with ruxolitinib (RUX) and examined any possible prognostic impact. Elevated RDW values were present in all but 4 patients at diagnosis with a median RDW of 18.9
更多查看译文
关键词
Myelofibrosis,Red cell distribution width,Ruxolitinib,Prognosis,Anemia
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要